Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06614855
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-24
Brief Title:
A Phase IB 2 Dose Trial of IRS-1 HSV C134 IND 17296 Administered Intratumorally in Patients with Recurrent Malignant Glioma
Sponsor:
Organization:
None